Enoxaparin Sodium Injection — Class I drug recall D-0286-2022
Completed recall by Sandoz Inc, reported 2021-12-08, distributed nationwide. Temperature Abuse; temperature excursion during shipping
| Recall number | D-0286-2022 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Completed |
| Voluntary or mandated | Voluntary |
| Recalling firm | Sandoz Inc, Princeton, NJ, United States |
| Recall initiated | 2021-11-17 |
| Classified | 2021-12-16 |
| Reported by FDA | 2021-12-08 |
| Distributed | Nationwide (US) |
| Quantity | 45,036 cartons |
| Reason classes | temperature control |
| NDC | 00781-3246-02, 00781-3246-64 |
| Lot numbers | SAB06761A |
| Expiration dates | 2023-04 |
Product
Enoxaparin Sodium Injection, USP, 40 mg/0.4 mL, Single-Dose Syringes with Automatic Safety Device, For Subcutaneous Injection, Rx Only; 0.4 mL Syringes, Manufactured for Sandoz Inc., Princeton, NJ 08540, NDC 00781-3246-02; Carton (10 x 0.4 mL Syringes), Manufactured by Shenzhen Techdow Pharmaceutical Co., Ltd. Shenzhen City, Guangdong Province 518057, China for Sandoz Inc., Princeton, NJ 08540, NDC 00781-3246-64
Reason for recall
Temperature Abuse; temperature excursion during shipping
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0286-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.